Staff Physician, Clinical Instructor, Oncology, Stanford University
Stanford, California, August 2002-present

Fellow, Oncology, Stanford University
Stanford, California, July 1999-July 2002

• Fellowship, Lymphoma Research Foundation, 2002-2004
  
• Research Project: Mechanism of Rituximab's Anti-Tumor Effect on Human Non-Hodgkin's Lymphoma
  
• Advisor: Dr. Ronald Levy, Chief, Division of Oncology, Department of Medicine, Stanford University School of Medicine

Resident, Internal Medicine, University of Texas at Houston Medical School
Houston, Texas, June 1996-June 1999

Ph.D., Laboratory Medicine and Pathology, University of Minnesota
Minneapolis, Minnesota, 1990-June 1996

• Andrew and Dorothy Bird Award, Sigma Xi Scientific Research Society, 1996
  
• Doctoral Dissertation Fellowship, University of Minnesota Graduate School, 1995-1996
  
• NIH/NIAID National Research Service Award, 1994-1995
  
• Research Assistant Fellowship, 1990-1994
  
• Member, Annual Immunology Retreat Organization Committee, University of Minnesota Immunology Group, 1995
  
• Research Project: Signal Transduction through a B-cell specific membrane protein CD19 and its role in human B cell development
  
• Advisor: Dr. Tucker W. LeBien, Professor of Laboratory Medicine and Pathology; Deputy Director, University of Minnesota Cancer Center

• Graduation GPA: 3.72, on a 4.0 scale
  
• Internship, Chang-Gung Memorial Hospital, Taipei, Taiwan, 1986- 1988
  
• Class representative, 1985-1986
  
• Research Assistant Fellowship, Department of Anatomy, 1984-1985
  
• Teaching Assistant Fellowship, Department of Biology, 1983
  
• Founder/Vice President, Chung-Shan Wildbird Club (Bird watching group), 1982-1983

• Member, American Society of Clinical Oncology, 2002-present
• Member, American Society of Hematology, 2001-present
• Member, Sigma Xi, The Scientific Research Society, 1996-present
• Reviewer, Journal of Clinical Oncology, 2004-present
• Reviewer, Blood, 1996, 2004-present
• Member, Chinese Medical Association, 1989-present

W.-K. Weng, D. Czerwinski, J. Timmerman, F.J. Hsu and R. Levy. 2004. Clinical outcome of lymphoma patients after idiotype vaccination is coorelated with humoral immune response and immunoglobulin G Fc receptor genotype. Journal of Clinical Oncology 21:3940-3947.

W.-K. Weng, and R. Levy. 2003. Two immunoglobulin G Fc receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. Journal of Clinical Oncology 21:3940-3947.

W.-K. Weng, and S. Levy. 2003. Hepatitis C Virus (HCV) and lymphomagenesis. Leukemia & Lymphoma 44:1113-1120.

W.-K. Weng, and R.Levy. 2001. Expression of complement inhibitors CD46, CD55 and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma. Blood 98:1352-1357.

W.-K. Weng *, N. Shah *, D. O'Brien, B. VanNess, and T. W. LeBien. 1997. Differential induction of DNA binding activities following CD19 cross-linking in human B lineage cells. J. Immunol. 159:5502-5508. (* The first two authors contributed equally to this work )

W.-K. Weng, L. Jarvis, and T.W. LeBien. 1994. Signaling through CD19 activates Vav/Mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/Phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514-32521.

M.L. Wolf *, W.-K. Weng *, K.T. Stieglbauer, N. Shah and T.W. LeBien. 1993. Functional effect of IL-7-enhanced CD19 expression on human B-cell precursors. J. Immunol. 151:138- 148. (* The first two authors contributed equally to this work )

W.-K. Weng. June 1996. Function of CD19 in human B cell precursors and its role in B cell development. Ph.D. Dissertation

W.-K. Weng, and R. Levy. 2002. Rituximab-induced Antibody-Dependent Cellular Cytotoxicity (ADCC) in Follicular Non-Hodgkin's Lymphoma. Blood 100:157a.
( Oral presentation at the 2002 Annual ASH Meeting, Philadelphia, Pennsylvania, December 2002)

W.-K. Weng, and R. Levy. 2002. Analysis of IgG Fc Receptor Fc[gamma]RIIIa Polymorphism in Relapsed Follicular Non-Hodgkin's Lymphoma Patients Treated with Rituximab. Blood 100:353a.
( Poster presentation at the 2002 Annual ASH Meeting, Philadelphia, Pennsylvania, December 2002 )

W.-K. Weng, C. Wang, K. Chu, and R. Levy. 2001. Human Anti-CD40 Antagonistic Antibodies Inhibit the Proliferation of Human B Cell Non-Hodgkin's Lymphoma. Blood
( Oral presentation at the 2001 Annual ASH Meeting, Orlando, Florida, December 2001)

W.-K. Weng, and R. Levy. 2001. Rituximab-induced Annexin-V Staining of Tumor Cells Does Not Predict Clinical Outcome Following Rituximab Treatment in Follicular Non-Hodgkin's Lymphoma. Blood
( Poster presentation at the 2001 Annual ASH Meeting, Orlando, Florida, December 2001 )

W.-K. Weng, D. O'Brien, B. VanNess, and T. W. LeBien. 1995. Signaling through CD19 activates different transcription factors in human B lineage cells depending on the stage of B cell development. 9th International Congress of Immunology Abstract 2657
( Oral presentation at the 9th International Congress of Immunology, San Francisco, California, July 1995 )

W.-K. Weng, D. O'Brien, B. VanNess, and T. W. LeBien. 1995. Signaling through CD19 activates AP1 transcription factors in human B lineage cells. FASEB J. 9:A214
( Poster presentation at the FASEB Experimental Biology 95 meeting, Atlanta, Georgia, April 1995 )

W.-K. Weng, M.L. Wolf and T.W. LeBien. 1993. Two adhesive pathways triggered through CD19 in B cell precursors have distinct characteristics. J. Cell. Biochem. supp. 17B:FZ147.
( Poster presentation at the Keystone Symposium-Molecular aspects of B lymphocyte differentiation, Taos, New Mexico, February 1993 )

M.L. Wolf, W.-K. Weng, J.B. McCarthy and T.W. LeBien. 1993. CD19 triggered cell aggregation in normal B cell precursors is mediated by an RDG specific binding event. J. Cell. Biochem. supp. 17B:FZ148.

• Physician License, California, December 1998-present
• USMLE: Step 1, June 1995; Step 2, August 1995; Step 3, December 1997
• ECFMG (Educational Commission for Foreign Medical Graduate) Certificate, October 1995
• Physician License for The Practice of Medicine, Taiwan, July 1989

• Director, Academic Committee, Minnesota Chinese Society in Biomedical Science, 1993-1996
  
• Consultant, Minnesota Chinese Student Association (MCSA), 1993-1996
  
• Volunteer of the year, Speaker in "Exploring the human body" series, National Museum of Natural History, Taichung, Taiwan, 1985-1986
  
• Wildlife photographer, Works have been published in several National Parks publications, calendar and birding guides in Taiwan.
  
• Webmaster, Bird of Taiwan Home Page

Tel: (650) 723-7621
eMail: wkweng@stanford.edu